October 08, 2013

Par Sterile Products, LLC v. Hospira Inc et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. May 12, 2015

    Hospira, Par Pharma Settle Epinephrine False Ad Suit

    A California federal judge signed off on a deal Tuesday to resolve claims brought by a unit of Par Pharmaceutical Inc. accusing Hospira Inc. of falsely marketing its products as being comparable to Par's FDA-approved version of the allergy treatment epinephrine.

2 other articles on this case. View all »


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!